Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT00440726 · COMPLETED
Trial details
- NCT number
- NCT00440726
- Sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-04
- Primary completion
- 2011-02-26
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.